REGISTER
The most significant advances in CAR-T therapy in 2025
Prof. Mei, Prof. Feng and Prof. Michot discussed the most significant advances in CAR-T therapy in 2025.

Prof. Heng Mei, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China
Prof. Jingjing Feng, The First Affiliated Hospital, Zhejiang University School of Medicine, China
Prof. Jean-Marie Michot, Gustave Roussy, France


Prof. Mei, Prof. Feng and Prof. Michot discussed the most significant advances in CAR-T therapy in 2025, including progress in novel targets, bispecific approaches, and safety optimization. They also explored how the treatment landscape is evolving through earlier-line use, expanded indications, and emerging combination strategies.

0
0
Loading